Jubilant Life hits 52-week high on DCGI nod for Remdesivir; Rakesh Jhunjhunwala raises stake in June quarter
The company's subsidiary Jubilant Generics has received the approval from Drug Controller General of India (DCGI) to manufacture and market investigational drug Remdesivir 100 mg/vial (lyophilized injection).